DEFA14A: Silexion Therapeutics Updates Record Date for 2025 Annual General Meeting
Proxy Statement Supplement
Silexion Therapeutics Corp. has filed a supplement to its definitive proxy statement, updating the record date for its 2025 annual general meeting to June 24, 2025.
Summary
- Silexion Therapeutics Corp. filed definitive proxy materials for its 2025 annual general meeting on June 16, 2025.
- The annual general meeting is scheduled for July 7, 2025, at 9:00 a.m. Eastern time / 4:00 p.m. local (Israel) time.
- The meeting will be held at the offices of Meitar Law Offices in Ramat Gan, Israel, with virtual attendance options available.
- The record date for shareholders entitled to notice of and to vote at the meeting has been updated to the close of business on Tuesday, June 24, 2025.
- The previously indicated record date was Monday, June 16, 2025.
- All other information related to the meeting, as stated in the originally filed definitive proxy statement, remains unchanged.
Sentiment
Score: 5
Explanation: The document is neutral, providing a factual administrative update regarding a record date change for an annual general meeting, with no positive or negative implications for the company's operations or financial health.
Future Outlook
The document primarily provides an administrative update regarding the record date for the upcoming 2025 annual general meeting, with no specific forward-looking statements or guidance on company performance.
Industry Context
This administrative update regarding a proxy statement and annual general meeting record date is a standard corporate governance procedure for publicly traded companies, ensuring compliance with regulatory requirements for shareholder participation. It does not provide specific insights into broader industry trends or competitive positioning.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Record Date Update | The record date for shareholders entitled to notice of, and to vote at, the 2025 annual general meeting has been updated from June 16, 2025, to June 24, 2025. | 2025-06-24 | This change ensures that the correct pool of shareholders is identified for voting purposes at the upcoming annual general meeting, aligning with regulatory requirements for shareholder participation. |
Stakeholder Impact
- Shareholders: The change in record date directly impacts which shareholders are eligible to receive notice of and vote at the 2025 annual general meeting.
Next Steps
- The 2025 annual general meeting will proceed as scheduled on July 7, 2025.
- Shareholders of record as of June 24, 2025, will be entitled to notice of and to vote at the meeting.
Key Dates
| Date | Description |
|---|---|
| 2025-06-16 | Original filing date of definitive proxy materials for the 2025 annual general meeting and previously indicated record date. |
| 2025-06-24 | Updated record date for shareholders entitled to notice of and to vote at the 2025 annual general meeting. |
| 2025-07-07 | Date of the 2025 annual general meeting, to be held at 9:00 a.m. Eastern time / 4:00 p.m. local (Israel) time. |
Keywords
Silexion Therapeutics, Proxy Statement, Annual General Meeting, Record Date, Corporate Governance, SEC Filing, DEFA14A
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.